The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
EXELIXIS INC | COM | 30161Q104 | 52,177,524 | 2,198,800 | SH | SOLE | 2,198,800 | 0 | 0 | |||
ESPERION THERAPEUTICS INC | COM | 29664W105 | 10,160,684 | 3,791,300 | SH | SOLE | 3,791,300 | 0 | 0 | |||
WISDOMTREE INDIA EARNINGS FUND | COM | 97717W422 | 2,644,092 | 60,700 | SH | SOLE | 60,700 | 0 | 0 | |||
ISHARES MSCI INDIA ETF | COM | 46429B598 | 3,066,228 | 59,400 | SH | SOLE | 59,400 | 0 | 0 |